Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Zealand Pharma A/S (ZLDPF) had Operating Cash Flow per Share of $13.82 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.40B |
|
$977.29M |
|
$0.12M |
|
$1.40B |
|
$341.47M |
|
$1.05B |
|
$6.30M |
|
$1.06B |
|
$1.06B |
|
$977.29M |
|
$977.29M |
|
$977.29M |
|
$977.29M |
|
$1.05B |
|
$1.06B |
|
70.50M |
|
71.55M |
|
$13.86 |
|
$13.66 |
|
| Balance Sheet Financials | |
$2.37B |
|
$10.58M |
|
$42.19M |
|
$2.41B |
|
$100.68M |
|
$45.86M |
|
$68.62M |
|
$169.29M |
|
$2.25B |
|
$2.24B |
|
$2.25B |
|
71.52M |
|
| Cash Flow Statement Financials | |
$988.93M |
|
$-340.42M |
|
$-57.26M |
|
$109.92M |
|
$692.89M |
|
$582.97M |
|
$17.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.57 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
99.99% |
|
75.52% |
|
75.52% |
|
75.82% |
|
75.98% |
|
70.05% |
|
$987.46M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
-- |
|
28.82 |
|
12.66 |
|
43.52% |
|
43.66% |
|
40.47% |
|
42.65% |
|
$31.40 |
|
$13.80 |
|
|
Operating Cash Flow per Share |
$13.82 |